Lexon × Jeff Koons Unveil the Chromatic Collection: a Colorful New Chapter for the Acclaimed Balloon Dog Lamp and Balloon Dog Speaker March 24, 2026 Eight new models introduce vibrant color variations, expanding the collection’s appeal to new and existing collectors alike.
Xsolla and Stevenage FC Launch Charity Campaign With SpecialEffect to Make Gaming Accessible for All March 24, 2026 Donation Of 50 Accessible Setups Reinforces Xsolla’s Commitment To Inclusive Gaming
Bank of England chief economist: Interest rates can ‘contain’ inflation March 24, 2026 The chief economist at the Bank of England has said interest rates can “contain” inflation as he vowed to act against the damaging effects of the war in Iran. Huw Pill, a member of the Bank’s Monetary Policy Committee, said he was focused on getting price growth down to two per cent in the medium [...]
Iran war: Staff at hedge fund Millennium weigh swapping Dubai for Jersey March 24, 2026 Hedge fund Millennium is exploring possible ways to settle staff who do not wish to return to Dubai in Jersey, as firms seek tax-favourable alternatives as the Middle Eastern conflict rages. The multi-manager firm, which had over 100 employees based in Dubai before the war broke out just under a month ago, is prepared to [...]
Cancel student debt in exchange for first time buyer equity, housebuilders urge government March 24, 2026 Cash-strapped graduates struggling to get on the property ladder should have their debt written off in exchange for giving over a stake of their first home to the government, a new report has urged. The report, backed by more than 50 housing sector bodies including top housebuilders Vistry and Barratt Redrow, proposes offering a discount [...]
Mike Lynch estate blocked from appealing HPE damages ruling March 24, 2026 The estate of the late British tech tycoon Mike Lynch has been refused permission to appeal a High Court ruling that found him liable to pay damages to Hewlett Packard Enterprise (HPE) over its acquisition of Autonomy. Lawyers acting for Lynch’s estate had sought to challenge the 2022 judgment, which held Lynch and Autonomy’s former [...]
Trian and General Catalyst Agree to Increase Merger Consideration to $52.00 Per Share in Cash for Janus Henderson Group plc and Have Made the Only Actionable Proposal March 24, 2026 Amended Merger Agreement Represents a $3.00 All-Cash Price Increase; 25% Premium to Unaffected Share Price; Parties Committed to Closing by Mid-2026 Special Committee Determines that Victory Capital’s Revised Unsolicited March 17, 2026 Proposal Is Not Actionable and Is Not in Best Interests of Janus Henderson and Its Shareholders Amended Merger Agreement’s All-Cash Transaction With Trian and General Catalyst Is Superior From an Expected Value and Certainty Perspective and Is the Only Actionable Proposal
ICON and Advarra Introduce New ‘Research-Ready,’ Connected Site Network Model March 24, 2026 Partnership will integrate ICON’s clinical trial technology with Advarra’s purpose-built system for research sites, embedded across a broad, deeply established global network. Partnership will reduce administrative friction, accelerate study startup, and increase clinical trial participation.
Compass Pathways Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Highlights March 24, 2026 COMP360 is the first classic psychedelic1 to consistently achieve a highly statistically significant result and clinically meaningful effect in treatment resistant depression (TRD), with a generally well-tolerated and safe profile Across three large trials in TRD, including two positive Phase 3 studies, COMP360’s differentiated profile is redefining rapidity and durability for TRD patients and demonstrating a consistent level of clinical effect that has never been achieved before Compass will meet with the FDA to confirm alignment on a rolling submission and review, and expects to complete the NDA submission in Q4 Compass is rapidly advancing commercial readiness plans and expects COMP360 will fit seamlessly across diverse healthcare settings at launch Phase 2b/3 trial in PTSD initiating, following FDA acceptance of IND application Successful $150 million financing in February and exercise of $200 million in warrants extends cash runway into 2028
TPG and Allianz Lead USD 350 Million Strategic Investment in Cambridge Mobile Telematics to Accelerate AI-Driven Road Safety March 24, 2026 Partnership to Expand Global Road Safety Platform and Real-Time AI Risk Models Accompanied by New Long-Term Commercial Agreements Between Allianz and CMT